The University of Chicago Header Logo

Connection

Andrzej Jakubowiak to Hematologic Neoplasms

Back to Details
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Hematologic Neoplasms.
Andrzej Jakubowiak
Connection Strength
0.165
Hematologic Neoplasms
  1. A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study. Future Oncol. 2022 Dec; 18(40):4443-4456.
    View in: PubMed
    Score: 0.165
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.